{"id":19112,"date":"2021-06-09T15:43:23","date_gmt":"2021-06-09T14:43:23","guid":{"rendered":"https:\/\/lscconnect.com\/consultantconnect\/?p=19112"},"modified":"2021-06-10T15:56:21","modified_gmt":"2021-06-10T14:56:21","slug":"the-4th-industrial-revolution-the-evolution-of-manufacturing","status":"publish","type":"post","link":"https:\/\/lscconnect.com\/consultantconnect\/blog\/2021\/06\/09\/the-4th-industrial-revolution-the-evolution-of-manufacturing\/","title":{"rendered":"The 4th Industrial Revolution \u2013 the evolution of manufacturing"},"content":{"rendered":"

As part of our commitment to continuous professional development, LSC are proudly sponsoring a series of ISPE Ireland Affiliate<\/a> virtual events in 2021.<\/p>\n

The latest webinar coming up on June 16th will focus on “The 4th Industrial Revolution \u2013 the evolution of manufacturing” <\/strong>with an incredible line of speakers and presentations – you won’t want to miss this! In the run up to the event we caught up with Philip Gammell<\/a> from Astellas,\u00a0 the event host to discuss challenges, the impact of Covid-19 and the benefits industry 4.0 will bring to pharma manufacturing.<\/p>\n

\"\"<\/p>\n

Hi Philip, can you tell us about your own career background? <\/strong><\/p>\n

I\u2019m a Pharmaceutical\/Biopharma professional with extensive experience in a range of technical and leadership positions in Manufacturing, Validation, Technology Transfer and Engineering. I have Experience in both large molecule (vaccine manufacture \u2013 I made Coronavirus Vaccines for Dogs 30 years ago!) and small molecule (API, OSD & Sterile fill-finish) manufacturing operations.<\/p>\n

Currently a member of Astellas’ Global Engineering and Digital Transformation function, specialising in development and introduction of innovative technologies and Pharma 4.0.<\/p>\n

How long have you been involved in the ISPE? <\/strong><\/p>\n

I have been a member of the ISPE for several years now, a Committee member since 2018 and Vice- president of ISPE Ireland Affiliate<\/a> since 2020. I also founded the ISPE Pharma 4IReland<\/em> group to address the challenges of introducing Industry 4.0 to Pharma\/Biopharma industry.<\/p>\n

What are the key challenges companies are facing in the application of Industry 4.0 to Pharma Manufacturing? <\/strong><\/p>\n